During the past decade, Service Néphrologie-Dialyse-Transplantation - CHU de Strasbourg - France conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Service Néphrologie-Dialyse-Transplantation - CHU de Strasbourg - France" are "Chronic Kidney Diseases" (1 trials), "IgA Nephropathy Severity in Kidney Transplantation" (1 trials), "Kidney Failure, Chronic" (1 trials) and "Renal Disease" (1 trials). Many other conditions were trialed in "Service Néphrologie-Dialyse-Transplantation - CHU de Strasbourg - France" in a lesser frequency.

Most popular intervention types in "Service Néphrologie-Dialyse-Transplantation - CHU de Strasbourg - France" are "Biological" (1 trials), "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "IgAN patients" (1 trials), "No oral anticoagulation" (1 trials) and "Oral anticoagulation with vitamin K antagonists" (1 trials). Other intervention names were less common.

The vast majority of trials in "Service Néphrologie-Dialyse-Transplantation - CHU de Strasbourg - France" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Service Néphrologie-Dialyse-Transplantation - CHU de Strasbourg - France". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Service Néphrologie-Dialyse-Transplantation - CHU de Strasbourg - France, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Service Néphrologie-Dialyse-Transplantation - CHU de Strasbourg - France, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".